BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 11259155)

  • 1. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
    Vulliamy TJ; Knight SW; Mason PJ; Dokal I
    Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
    de la Fuente J; Dokal I
    Pediatr Transplant; 2007 Sep; 11(6):584-94. PubMed ID: 17663679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyskeratosis congenita: a genetic disorder of many faces.
    Kirwan M; Dokal I
    Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskeratosis congenita.
    Handley TP; McCaul JA; Ogden GR
    Oral Oncol; 2006 Apr; 42(4):331-6. PubMed ID: 16140563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskeratosis congenita.
    Vulliamy T; Dokal I
    Semin Hematol; 2006 Jul; 43(3):157-66. PubMed ID: 16822458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cells, telomerase and dyskeratosis congenita.
    Mason PJ
    Bioessays; 2003 Feb; 25(2):126-33. PubMed ID: 12539238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
    Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
    PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita.
    Kanegane H; Kasahara Y; Okamura J; Hongo T; Tanaka R; Nomura K; Kojima S; Miyawaki T
    Br J Haematol; 2005 May; 129(3):432-4. PubMed ID: 15842668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A telomerase component is defective in the human disease dyskeratosis congenita.
    Mitchell JR; Wood E; Collins K
    Nature; 1999 Dec; 402(6761):551-5. PubMed ID: 10591218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskeratosis congenita: a disorder of defective telomere maintenance?
    Walne AJ; Marrone A; Dokal I
    Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.
    Ruggero D; Grisendi S; Piazza F; Rego E; Mari F; Rao PH; Cordon-Cardo C; Pandolfi PP
    Science; 2003 Jan; 299(5604):259-62. PubMed ID: 12522253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
    Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
    Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel mutation in DKC1 in dyskeratosis congenita.
    Kurnikova M; Shagina I; Khachatryan L; Schagina O; Maschan M; Shagin D
    Pediatr Blood Cancer; 2009 Jan; 52(1):135-7. PubMed ID: 18802941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
    Polychronopoulou S; Koutroumba P
    Acta Haematol; 2004; 111(3):125-31. PubMed ID: 15034232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice.
    He J; Navarrete S; Jasinski M; Vulliamy T; Dokal I; Bessler M; Mason PJ
    Oncogene; 2002 Oct; 21(50):7740-4. PubMed ID: 12400016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone marrow failure due to telomere associated gene mutation].
    Yamaguchi H; Dan K
    Rinsho Ketsueki; 2010 Aug; 51(8):646-53. PubMed ID: 20805671
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita.
    Parry EM; Alder JK; Lee SS; Phillips JA; Loyd JE; Duggal P; Armanios M
    J Med Genet; 2011 May; 48(5):327-33. PubMed ID: 21415081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1.
    Heiss NS; Bächner D; Salowsky R; Kolb A; Kioschis P; Poustka A
    Genomics; 2000 Jul; 67(2):153-63. PubMed ID: 10903840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.